| Original language | English |
|---|---|
| Article number | 253 |
| Pages (from-to) | 344-345 |
| Number of pages | 2 |
| Journal | Hematological Oncology |
| Volume | 39 |
| Issue number | Supp 2 |
| Publication status | Published - Jun 2021 |
| Event | International Conference on Malignant Lymphoma 2021 - Virtual, Lugano, Switzerland Duration: 18 Jun 2021 → 21 Jun 2021 Conference number: 16th https://www.icml.ch/icml/16th-icml-redirect/general-information.html |
A phase III trial of glofitamab plus gemcitabine and oxaliplatin (gemox) vs rituximab plus gemox for relapsed/refractory diffuse large B-cell lymphoma
Mark S. Hertzberg, Matthew Ku, Olivier Catalani, Betsy Althaus, Steven Simko, Gareth Peter Gregory
Research output: Contribution to journal › Meeting Abstract › peer-review